STEPHANIE STEBELTON: Open Payments
NPI 1114262458 · WARREN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,431 in 70 payments from 15 companies in 2025. Trend: 2023 $2,002 · 2024 $2,211 · 2025 $1,431
Food & beverage: $1,431
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $566 |
| Janssen Biotech, Inc. | 4 | $224 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $162 |
| QOL Medical, LLC | 3 | $73 |
| Medtronic, Inc. | 2 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| Ipsen Biopharmaceuticals, Inc | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| GENZYME CORPORATION | 1 | $38 |
| Celltrion USA Inc. | 2 | $36 |
Products named: TREMFYA, RINVOQ, SKYRIZI, ENTYVIO, DUPIXENT, Sucraid, INTERSTIM, CREON.
Industry payments across OH — which companies pay providers there.
